Sinco Pharmaceuticals Holdings logo

6833 - Sinco Pharmaceuticals Holdings News Story

HK$0.59 0.0  0.0%

Last Trade - 8:41am

Sector
Consumer Defensives
Size
Small Cap
Market Cap £92.9m
Enterprise Value £85.9m
Revenue £227.3m
Position in Universe 3416th / 6094

BRIEF-Sinco Pharmaceuticals Expects FY Consol Net Profit Of About RMB22 Mln To RMB32 Mln

Thu 5th March, 2020 10:25am
March 5 (Reuters) - Sinco Pharmaceuticals Holdings Ltd
 6833.HK :
    * EXPECTED TO RECORD A CONSOLIDATED NET PROFIT OF ABOUT
RMB22
MILLION TO RMB32 MILLION FOR YEAR
    * EXPECTED RESULT DUE TO OVERALL DECREASE IN GROUP'S SELLING
AND
DISTRIBUTION EXPENSES IN CURRENT PERIOD
    * SINCO PHARMACEUTICALS HOLDINGS LTD SEES FY CONSOL NET
PROFIT OF
ABOUT RMB22 MILLION TO RMB32 MILLION VERSUS LOSS OF RMB280.6
MILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS6pWfvp
Further company coverage:  6833.HK 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.